The Food and Drug Administration has approved a drug, Revolution Medicines’ Rasonque or daraxonrasib, that experts predict will transform treatment for pancreatic cancer. Dr. Philip Philip, an internationally renowned medical oncologist and co-Leader of the Pancreatic Cancer Program at Henry Ford Health, talked with WWJ's Kyle Kimball. (Photo credit: Getty Images)
